A biotech company says it put dopamine-making cells into people’s brains to treat Parkinson's Disease

Good news! This is my second blog post today on new treatments for Parkinson's.

"In an important test for stem-cell medicine, a biotech company says implants of lab-made neurons introduced into the brains of 12 people with Parkinson’s disease appear to be safe and may have reduced symptoms for some of them.

The added cells should produce the neurotransmitter dopamine, a shortage of which is what produces the devastating symptoms of Parkinson’s, including problems moving.  ..."

A biotech company says it put dopamine-making cells into people’s brains | MIT Technology Review The experiment to treat Parkinson’s is a critical early test of stem cells’ potential to tackle serious disease.

BlueRock’s Phase I study with bemdaneprocel in patients with Parkinson’s disease meets primary endpoint